The 2012 Jeffrey M. Trent Lectureship in Cancer Research
Cancer Genomes and Their Implications for Basic and Applied Research
The 10th annual Jeffrey M. Trent Lectureship in Cancer Research will be held on Wednesday, February 29, 2012, at 10 a.m.. The presenter is Bert Vogelstein, M.D., Clayton Professor of Oncology and Pathology, and director of the Ludwig Center for Cancer Genetics and Therapeutics at the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine. Dr. Vogelstein is also a Howard Hughes Medical Institute investigator. The lecture is convened by the National Human Genome Research Institute's Division of Intramural Research, and will be held at the Natcher Conference Center (Building 45) on the National Institutes of Health (NIH) campus in Bethesda, Md.
About the Lecturer
Dr. Vogelstein was the first researcher to elucidate the molecular basis of a common human cancer. His work on colorectal cancers forms the paradigm for much of modern cancer research, with profound implications for diagnostic and therapeutic strategies in the future.
Excellent academic and medical training set the foundation for Dr. Vogelstein's illustrious science career. He earned his medical degree at the Johns Hopkins University School of Medicine and completed his residency in pediatrics at the Johns Hopkins Hospital. Following his clinical training, Dr. Vogelstein also completed a post-doctoral fellowship at the National Cancer Institute, focusing on the development of new approaches to the study of human cancers.
Dr. Vogelstein has received numerous awards recognizing his pioneering studies on the pathogenesis of human cancers. He is a member of the American Academy of Arts and Sciences, the National Academy of Sciences, the American Philosophical Society, the Institute of Medicine and the European Molecular Biology Organization (EMBO). His advisory roles have included chairmanships for the National Research Council Committee on the Biological and Biomedical Applications of Stem Cell Research and the Board of Scientific Counselors of the National Human Genome Research Institute (NHGRI). According to the Institute for Scientific Information, Dr. Vogelstein is currently the most highly cited scientist in the world.
About the Jeffrey M. Trent Lectureship in Cancer Research
Dr. Trent was the National Human Genome Research Institute's founding scientific director, serving in this role for more than nine years. His leadership and vision was instrumental in establishing NHGRI's Division of Intramural Research as one of the premier research programs in the world devoted to genetics and genomics. In recognition of his significant contributions to the research environment at NIH, NHGRI established the annual Jeffrey M. Trent Lectureship in Cancer Research in 2003. This lecture is given by a prominent cancer researcher who brings the kind of energy, creativity and enthusiasm to cancer research that Dr. Trent has exemplified throughout his career.
More information about Dr. Vogelstein and his research can be found at:
- Bert Vogelstein, M.D., Howard Hughes Medical Institute [hhmi.org]
- Dr. Bert Vogelstein, Johns Hopkins Medicine [hopkinsmedicine.org]
- The Giants of Science: The Guardian discusses vogelstein's ranking as the world's leading scientist [guardian.co.uk]
For additional information:
Phone: (301) 451-9648
Last Reviewed: November 14, 2012
Leave a Comment!
We encourage you to share your thoughts as they relate to the topics being discussed on genome.gov, other websites or discussion forums owned or administered by the National Human Genome Research Institute (NHGRI). We review all comments for posting. We do not discriminate against any views, but we reserve the right not to post comments, or to remove comments, that are inconsistent with our Comment Policy, at our complete discretion.